Shyh-Dar Li PhD
Professor
Dr. Shyh-Dar Li received his BSc in pharmacy from National Taiwan University in 1998 and PhD in pharmaceutical sciences from the University of North Carolina at Chapel Hill in 2008. He finished his postdoctoral training at Moores Cancer Center at the University of California, San Diego in 2009. He is now an associate professor at UBC Pharmaceutical Sciences.
Dr. Li has won several research awards, including 2014 AFPC New Investigator Award, 2013 AAPS New Investigator Award in Pharmaceutics and Pharmaceutical Technologies, 2013 CIHR New Investigator Award, 2013 CSPS Early Career Award, and 2012 Prostate Cancer Foundation Young Investigator Award. He is the chair-elect of the Targeted Drug Delivery and Prodrug Focus Group of AAPS and an Academic Editor of BioMed Research International.
Dr. Li's research focuses on developing innovative drug delivery systems to enhance cancer chemotherapy. His research program has been supported by NIH and CIHR.
Ernsting MJ, Hoang B, Lohse I, Undzys E, Cao P, Do T, Gill B, Pintilie M, Hedley D, Li SD. Targeting of metastasis-promoting tumor-associated fibroblasts and modulation of pancreatic tumor-associated stroma with a carboxymethylcellulose-docetaxel nanoparticle. J Control Release. 2015 May 28;206:122-30. doi: 10.1016/j.jconrel.2015.03.023. Epub 2015 Mar 21. PMID: 25804872; PMCID: PMC4409566.
Roy A, Ernsting MJ, Undzys E, Li SD. A highly tumor-targeted nanoparticle of podophyllotoxin penetrated tumor core and regressed multidrug resistant tumors. Biomaterials. 2015 Jun;52:335-46. doi: 10.1016/j.biomaterials.2015.02.041. Epub 2015 Mar 3. PMID: 25818440; PMCID: PMC4379456.
